CD8A and neoplasm: Those observations support the hypothesis that IL-21 may be useful for promoting the cytotoxic function of peripheral CD8+ T cells, but because exogenous γc cytokine treatment may disrupt antigen-priming, only after a population of activated, tumor-reactive CD8+ T cells is well-established.